Trial Outcomes & Findings for Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery (NCT NCT03745794)
NCT ID: NCT03745794
Last Updated: 2025-12-23
Results Overview
Performed Chi-squared test to compare the proportion of patients who were opioid-free on the discharge date between the two arms
Recruitment status
COMPLETED
Study phase
PHASE2
Target enrollment
136 participants
Primary outcome timeframe
90 days from surgery
Results posted on
2025-12-23
Participant Flow
30 participants were excluded from the study before assignment to arms due to aborted surgery, discharged before 4 days after surgery or opioids free at 3rd day after surgery.
Participant milestones
| Measure |
Arm 1, Control Arm (Usual Care)
Patients undergo QL block before surgery and receive standard of care multimodal pain control after surgery.
|
Arm 2, Experimental Arm (2nd QL-Block)
Patients undergo QL block before surgery and receive multimodal pain control. Patients then undergo a second QL block on day 4 after surgery and continue to receive standard of care.
|
|---|---|---|
|
Overall Study
STARTED
|
52
|
54
|
|
Overall Study
COMPLETED
|
52
|
53
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
Baseline characteristics by cohort
| Measure |
Arm 2, Experimental Arm (2nd QL-Block)
n=53 Participants
Patients undergo QL block before surgery and receive multimodal pain control. Patients then undergo a second QL block on day 4 after surgery and continue to receive standard of care.
|
Total
n=105 Participants
Total of all reporting groups
|
Arm 1, Control Arm (Usual Care)
n=52 Participants
Patients undergo QL block before surgery and receive standard of care multimodal pain control after surgery.
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=4 Participants
|
0 Participants
n=219 Participants
|
0 Participants
n=68 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
19 Participants
n=4 Participants
|
46 Participants
n=219 Participants
|
27 Participants
n=68 Participants
|
|
Age, Categorical
>=65 years
|
34 Participants
n=4 Participants
|
59 Participants
n=219 Participants
|
25 Participants
n=68 Participants
|
|
Age, Continuous
|
65 years
STANDARD_DEVIATION 11.2 • n=4 Participants
|
64 years
STANDARD_DEVIATION 11.8 • n=219 Participants
|
63 years
STANDARD_DEVIATION 12.5 • n=68 Participants
|
|
Sex: Female, Male
Female
|
23 Participants
n=4 Participants
|
47 Participants
n=219 Participants
|
24 Participants
n=68 Participants
|
|
Sex: Female, Male
Male
|
30 Participants
n=4 Participants
|
58 Participants
n=219 Participants
|
28 Participants
n=68 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=4 Participants
|
8 Participants
n=219 Participants
|
6 Participants
n=68 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
49 Participants
n=4 Participants
|
93 Participants
n=219 Participants
|
44 Participants
n=68 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=4 Participants
|
4 Participants
n=219 Participants
|
2 Participants
n=68 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=4 Participants
|
1 Participants
n=219 Participants
|
1 Participants
n=68 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=4 Participants
|
4 Participants
n=219 Participants
|
3 Participants
n=68 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=4 Participants
|
0 Participants
n=219 Participants
|
0 Participants
n=68 Participants
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=4 Participants
|
5 Participants
n=219 Participants
|
1 Participants
n=68 Participants
|
|
Race (NIH/OMB)
White
|
48 Participants
n=4 Participants
|
94 Participants
n=219 Participants
|
46 Participants
n=68 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=4 Participants
|
0 Participants
n=219 Participants
|
0 Participants
n=68 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=4 Participants
|
1 Participants
n=219 Participants
|
1 Participants
n=68 Participants
|
|
Region of Enrollment
United States
|
53 participants
n=4 Participants
|
105 participants
n=219 Participants
|
52 participants
n=68 Participants
|
PRIMARY outcome
Timeframe: 90 days from surgeryPopulation: one participant inevaluable for analysis.
Performed Chi-squared test to compare the proportion of patients who were opioid-free on the discharge date between the two arms
Outcome measures
| Measure |
Arm 1, Control Arm (Usual Care)
n=52 Participants
Patients undergo QL block before surgery and receive standard of care multimodal pain control after surgery.
|
Arm 2, Experimental Arm (2nd QL-Block)
n=53 Participants
Patients undergo QL block before surgery and receive multimodal pain control. Patients then undergo a second QL block on day 4 after surgery and continue to receive standard of care.
|
|---|---|---|
|
Number of Participants Discharged Opioid-Free
|
19 Participants
|
27 Participants
|
SECONDARY outcome
Timeframe: Up to 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 1 yearTwo sample t-test.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: through study completion, an average of 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: At 30 days after surgeryTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Up to 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: At 90 days after surgeryTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: At 30 and 90 daysTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: At 6 months and 1 yearTwo sample t-test or Wilcoxon rank-sum test will be used.
Outcome measures
Outcome data not reported
Adverse Events
Arm 1, Control Arm (Usual Care)
Serious events: 10 serious events
Other events: 39 other events
Deaths: 3 deaths
Arm 2, Experimental Arm (2nd QL-Block)
Serious events: 10 serious events
Other events: 31 other events
Deaths: 3 deaths
Serious adverse events
| Measure |
Arm 1, Control Arm (Usual Care)
n=52 participants at risk
Patients undergo QL block before surgery and receive standard of care multimodal pain control after surgery.
|
Arm 2, Experimental Arm (2nd QL-Block)
n=54 participants at risk
Patients undergo QL block before surgery and receive multimodal pain control. Patients then undergo a second QL block on day 4 after surgery and continue to receive standard of care.
|
|---|---|---|
|
Gastrointestinal disorders
Delayed Gastric Emptying
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
Pancreatic leak
|
7.7%
4/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
BJ leak
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
Chyle leak
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
GI Other
|
5.8%
3/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Other
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Blood and lymphatic system disorders
Hemorrhage
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Blood and lymphatic system disorders
Hematologic_ other
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Abscess
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Sterile collection
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Line infection
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Sepsis
|
3.8%
2/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Infectious Other
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
Other adverse events
| Measure |
Arm 1, Control Arm (Usual Care)
n=52 participants at risk
Patients undergo QL block before surgery and receive standard of care multimodal pain control after surgery.
|
Arm 2, Experimental Arm (2nd QL-Block)
n=54 participants at risk
Patients undergo QL block before surgery and receive multimodal pain control. Patients then undergo a second QL block on day 4 after surgery and continue to receive standard of care.
|
|---|---|---|
|
Gastrointestinal disorders
Delayed Gastric Emptying
|
15.4%
8/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
13.0%
7/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
Pancreatic leak
|
15.4%
8/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
13.0%
7/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
Chyle leak
|
3.8%
2/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
7.4%
4/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Gastrointestinal disorders
GI Other
|
17.3%
9/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
5.6%
3/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Cardiac disorders
Arrythmia
|
3.8%
2/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Respiratory, thoracic and mediastinal disorders
Edema
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Blood and lymphatic system disorders
Hemorrhage
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Blood and lymphatic system disorders
Post-op transfusion
|
7.7%
4/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
9.3%
5/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Blood and lymphatic system disorders
Hematologic_ other
|
3.8%
2/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Renal and urinary disorders
Acute Renal Failure
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Renal and urinary disorders
Renal other
|
5.8%
3/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
5.6%
3/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Abscess
|
0.00%
0/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Cholangitis
|
5.8%
3/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Urinary Tract Infection
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Wound infection
|
13.5%
7/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Colitis
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Infections and infestations
Infectious Other
|
11.5%
6/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
1.9%
1/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Nervous system disorders
Neurologic_Other
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
3.7%
2/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
|
Metabolism and nutrition disorders
Metabolic Other
|
1.9%
1/52 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
0.00%
0/54 • 90 days from surgery
All surgical complications for 90 days after the surgery were recorded. They were all unrelated to the QL-Block. The MDASI questionnaire survey were collected from 3/1/2019 to 11/29/2021. All deaths were unrelated to the QL-Block. In Arm 2, 53 participants were recorded as 1 of the 54 participants dropped out. We were unable to officially track the 90 day outcomes for that participant.
|
Additional Information
Dr. Ching-Wei D. Tzeng, MD/Associate Professor, Surgical Oncology
UT MD Anderson Cancer Center
Phone: (713) 792-0386
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place